The Ductus Arteriosus: A Refined Approach!

Seminars in Perinatology

Volumn 36, Issue 2, 2012, Pages 105-113

  Sehgal, Arvind ^a,b   McNamara, Patrick J ^c,d  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Patent ductus arteriosus

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTERY LIGATION; CORONARY ARTERY BLOOD FLOW; DISEASE CLASSIFICATION; DISEASE MARKER; DOPPLER ECHOGRAPHY; DUCTUS ARTERIOSUS; ECHOCARDIOGRAPHY; HUMAN; INTESTINE PERFORATION; KIDNEY DISEASE; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NONHUMAN; PATENT DUCTUS ARTERIOSUS; POSTOPERATIVE COMPLICATION; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SIDE EFFECT;

BIOLOGICAL MARKERS; CYCLOOXYGENASE INHIBITORS; DECISION MAKING; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PREGNANCY;

EID: 84858250836     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2011.09.020     Document Type: Review

References (88)

1. Van Overmeire B., Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 2005, 10:177-184.
2. Santhanam S., Walker K., Shingde V., et al. Patent ductus arteriosus in preterm babies <32 weeks in NSW and the ACT over the period 1992-2005: Risk factors, associated morbidities and outcome. J Paediatr Child Health 2008, 44:A12-A59. NICUS Group.
3. Bose C.L., Laughon M.M. Patent ductus arteriosus: Lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007, 92:F498-F502.
4. Benitz W.E. Treatment of persistent patent ductus arteriosus in preterm infants: Time to accept the null hypothesis?. J Perinatol 2010, 30:241-252.
5. Clyman R.I., Chorne N. Patent ductus arteriosus: Evidence for and against treatment. J Pediatr 2007, 150:216-219.
6. Garland J., Buck R., Weinberg M. Pulmonary haemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: A retrospective cohort study. Pediatrics 1994, 94:719-723.
7. Laughon M., Bose C., Clark R. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. J Perinatol 2007, 27:164-170.
8. Laughon M.M., Simmons M.A., Bose C.L. Patency of the ductus arteriosus in the premature infant: Is it pathologic? Should it be treated?. Curr Opin Pediatr 2004, 16:146-151.
9. Trus T., Winthrop A.L., Pipe S., et al. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. J Pediatr Surg 1993, 28:1137-1139.
10. Edwards A.D., Wyatt J.S., Richardson C., et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990, 335:1491-1495.
11. Seyberth H.W., Rascher W., Hackenthal R., et al. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. J Pediatr 1983, 103:979-984.
12. Heymann M.A., Rudolph A.M., Silverman N.H. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976, 295:530-533.
13. Friedman W.F., Hirschklau M.J., Printz M.P., et al. Pharmacologic closure of patent ductus arteriosus in the premature infants. N Engl J Med 1976, 295:526-529.
14. Abbasi S., Jeffrey S., Gerdes J.S., et al. Neonatal outcome after exposure to indomethacin in utero: A retrospective case cohort study. Am J Obstet Gynecol 2003, 189:782-785.
15. Amin B.S., Sinkin R., Glantz J.C. Metanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol 2007, 486:e1-e10.
16. Fejgin M.D., Delpino M.L., Bidiwala K.S. Isolated small bowel perforation following intrauterine treatment with indomethacin. Am J Perinatol 1994, 11:295-296.
17. Sharma R., Hudak M.L., Tepas J.J., et al. Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis. J Perinatol 2010, 30:786-793.
18. Sehgal A., McNamara P.J. Indomethacin Impairs Coronary Perfusion in Infants with Hemodynamically Significant Ductus Arteriosus. Neonatology 2012, 101:20-27.
19. Way G.L., Pierce J.R., Wolfe R.R., et al. ST depression suggesting subendocardial ischemia in neonates with respiratory distress syndrome and patent ductus arteriosus. J Pediatr 1979, 95:609.
20. Evans N., Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996, 75:F183-F186.
21. Shimada S., Kasai T., Hoshi A., et al. Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int 2003, 45:255-262.
22. Swarup J., Baker R.W., Brozanski B.S., et al. Asymmetry of cerebral blood flow velocity in low birth weight infants. Biol Neonate 2005, 87:145-151.
23. Koehne P.S., Bein G., Alexi-Meskhishvili V., et al. Patent ductus arteriosus in very low birth weight infants: Complications of pharmacological and surgical treatment. J Perinat Med 2001, 29:327-334.
24. Van Overmeire B., Van de Broek H., Van Laer P., et al. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 2001, 138:205-211.
25. Koch J., Hensley G., Roy L., et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006, 117:1113-1121.
26. Schmidt B., Davis P., Moddemann D., et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001, 344:1966-1972. Trial of Indomethacin Prophylaxis in Preterms Investigators.
27. Gournay V., Roze J.C., Kuster A., et al. Prophylactic ibuprofen versus placebo in very premature infants: A randomised, double-blind, placebo-controlled trial. Lancet 2004, 364:1939-1944.
28. Van Overmeire B., Allegaert K., Casaer A., et al. Prophylactic ibuprofen in premature infants: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004, 364:1945-1949.
29. Knight D.B. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001, 6:63-73.
30. Clement W.A., El-Hakim H., Phillipos E.Z., et al. Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants. Arch Otolaryngol Head Neck Surg 2008, 134:28-33.
31. Smith M.E., King J.D., Elsherif A., et al. Should all newborns who undergo patent ductus arteriosus ligation be examined for vocal fold mobility?. Laryngoscope 2009, 119:1606-1609.
32. Mandhan P., Brown S., Kukkady A., et al. Surgical closure of patent ductus arteriosus in preterm low birth weight infants. Congenit Heart Dis 2009, 4:34-37.
33. Gould D.S., Montenegro L.M., Gaynor J.W., et al. A comparison of on-site and off-site patent ductus arteriosus ligation in premature infants. Pediatrics 2003, 112:1298-1301.
34. Shelton J.E., Julian R., Walburgh E., et al. Functional scoliosis as a long-term complication of surgical ligation for patent ductus arteriosus in premature infants. J Pediatr Surg 1986, 21:855-857.
35. Kabra N.S., Schmidt B., Roberts R.S., et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: Results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007, 150:229-234. Trial of Indomethacin Prophylaxis in Preterms Investigators.
36. Chorne N., Leonard C., Piecuch R., et al. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007, 119:1165-1174.
37. Noori S., Friedlich P., Seri I., et al. Changes in myocardial function and haemodynamics after ligation of the ductus arteriosus in preterm infants. J Pediatr 2007, 150:597-602.
38. Sehgal A., Francis J.V., James A., et al. Patent ductus arteriosus ligation and post-operative hemodynamic Instability: Case report and framework for enhanced neonatal care. Indian J Pediatr 2010, 77:905-907.
39. Mittal A., Dos Santos S., Hellman J., et al. PDA categorisation predicts post-ligation need for cardiotropes. Pediatric Academic Societies Annual Meeting 2008, E-PAS 5842.
40. Teixeira L.S., Shivananda S.P., Stephens D., et al. Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention. J Perinatol 2008, 28:803-810.
41. McNamara P.J., Stewart L., Sandesh S.P., et al. PDA ligation is associated with postoperative myocardial dysfunction in premature infants. J Thorac Cardiovasc Surg 2010, 140:150-157.
42. Sehgal A., McNamara P.J. Coronary Artery Hypo-Perfusion Is Associated with Impaired Diastolic Dysfunction in preterm Infants after patent ductus arteriosus (PDA) Ligation. Pediatric Academic Societies Annual Meeting 2007, E-PAS 5896.
43. Lemmers P.M., Molenschot M.C., Evens J., et al. Is cerebral oxygen supply compromised in preterm infants undergoing surgical closure for patent ductus arteriosus?. Arch Dis Child Fetal Neonatal Ed 2010, 95:F429-F434.
44. Leslie A.T., Keyzers M., EL-Khuffash A., et al. Impact of patent ductus arteriosus (PDA) Ligation on Cerebral Electrical Activity in preterm Infants. Pediatric Academic Societies Annual Meeting 2011, E-PAS 4455.7.
45. Loeliger M., Inder T.E., Dalitz P.A., et al. Developmental and neuropathological consequences of ductal ligation in the preterm baboon. Pediatr Res 2009, 65:209-214.
46. Coalson J.J., Winter V.T., Siler-Khodr T., et al. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999, 160:1333-1346.
47. Shimada S., Kasai T., Konishi M., et al. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr 1994, 125:270-277.
48. Martin C.G., Snider A.R., Katz S.M., et al. Abnormal cerebral blood flow patterns in preterm infants with a large patent ductus arteriosus. J Pediatr 1982, 101:587-593.
49. Coombs R.C., Morgan M.E., Durbin G.M., et al. Gut blood flow velocities in the newborn: Effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990, 65:1067-1071.
50. Groves A.M., Kuschel C.A., Knight D.B., et al. Does retrograde diastolic flow in the descending aorta signify impaired systemic perfusion in preterm infants?. Pediatr Res 2008, 63:89-94.
51. Clyman R.I., Mauray F., Heymann M.A., et al. Cardiovascular effects of patent ductus arteriosus in preterm lambs with respiratory distress. J Pediatr 1987, 111:579-587.
52. Marshall D.D., Kotelchuck M., Young T.E., et al. Risk factors for chronic lung disease in the surfactant era: A North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 1999, 104:1345-1350.
53. Dollberg S., Lusky A., Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: A population-based study. J Pediatr Gastroenterol Nutr 2005, 40:184-188.
54. Noori S., McCoy M., Friedlich P., et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009, 123:e138.
55. Brooks J.M., Travadi J.N., Patole S.K., et al. Is surgical ligation of patent ductus arteriosus necessary?. The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005, 90:F235-F239.
56. Cassady G., Crouse D.T., Kirklin J.W., et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989, 320:1511-1516.
57. Kawase Y., Ishii T., Arai H., et al. Gastrointestinal perforation in very low-birthweight infants. Pediatr Int 2006, 48:599-603.
58. Attridge J.T., Clark R., Walker M.W., et al. New insights into intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006, 26:93-99.
59. Loe S.M., Sanchez-Ramos L., Kaunitz A.M. Assessing the neonatal safety of indomethacin tocolysis: A systematic review with meta-analysis. Obstet Gynecol 2005, 106:173-179.
60. Fujii A.M., Brown E., Mirochnick M., et al. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. J Perinatol 2002, 22:535-540.
61. Grosfeld J.L., Chaet M., Molinari F., et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg 1996, 224:350-355.
62. Leonhardt A., Seyberth H.W. Do we need another NSAID instead of indomethacin for treatment of ductus arteriosus in preterm infants?. Acta Paediatr 2003, 92:996-999.
63. Clyman R.I. Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategies. J Pediatr 1996, 128:601-607.
64. Cooke L., Steer P., Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003, 2. CD00374.
65. Evans N. Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants. Adv Neonatal Care 2003, 3:168-177.
66. Evans N., Iyer P. Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: Correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed 1995, 72:F156-F161.
67. McNamara P.J., Sehgal A. Towards rational management of the patent ductus arteriosus: The need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007, 92:F424-F427.
68. Sehgal A., McNamara P.J. Staging the ductus arteriosus facilitates identification of neonates at increased risk of respiratory morbidity. J Neonatal Perinatal Med 2010, 4:14-17.
69. El-Khuffash A.F., McNamara P.J. The patent ductus arteriosus ligation decision. J Pediatr 2011, 158:1037-1038.
70. EL-Khuffash A.F., Slevin M., McNamara P.J., et al. Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Arch Dis Child Fetal Neonatal Ed 2011, 96:F133-F137.
71. El-Khuffash A.F., Amoruso M., Culliton M., et al. N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: A prospective observational study. Arch Dis Child Fetal Neonatal Ed 2007, 92:421-422.
72. El-Khuffash A.F., Molloy E.J. Influence of a patent ductus arteriosus on cardiac troponin T levels in preterm infants. J Pediatr 2008, 153:350-353.
73. Evans N., Gournay V., Cabanas F., et al. Point-of-care ultrasound in the neonatal intensive care unit: International perspectives. Semin Fetal Neonatal Med 2011, 16:61-68.
74. Kluckow M., Seri I., Evans N. Functional echocardiography: An emerging clinical tool for the neonatologist. J Pediatr 2007, 150:125-130.
75. Kluckow M., Seri I., Evans N. Echocardiography and the neonatologist. Pediatr Cardiol 2008, 29:1043-1047.
76. Kluckow M., Evans N. Superior vena cava flow in newborn infants: A novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed 2000, 82:F182-F187.
77. Kluckow M., Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000, 82:F188-F194.
78. O'Rourke D.J., El-Khuffash A., Moody C., et al. Patent ductus arteriosus evaluation by serial echocardiography in preterm infants. Acta Paediatr 2008, 97:574-578.
79. Jain A., Sahni M., Khadawardi E., et al. Targeted Neonatal Echocardiography (TnECHO) Prevents postoperative Cardiorespiratory Instability Following PDA Ligation. Pediatric Academic Societies Annual Meeting 2011, E-PAS 3808.39.
80. Friedman Z., Demers L.M., Marks K.H., et al. Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants. J Pediatr 1978, 93:512-515.
81. Sehgal A., Mak W., Dunn M., et al. Haemodynamic changes after delivery room surfactant administration to very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2010, 95:F345-F351.
82. Skinner J.R., Hunter S., Poets C.F., et al. Haemodynamic effects of altering arterial oxygen saturation in preterm infants with respiratory failure. Arch Dis Child Fetal Neonatal Ed 1999, 80:F81-F87.
83. El Hajjar M., Vaksmann G., Rakza T., et al. Severity of the ductal shunt: A comparison of different markers. Arch Dis Child Fetal Neonatal Ed 2005, 90:F419-F422.
84. Iyer P., Evans N. Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child 1994, 70:F112-F117.
85. Serwer G.A., Armstrong B.E., Anderson P.A. Continuous wave Doppler ultrasonographic quantitation of patent ductus arteriosus flow. J Pediatr 1982, 100:297-299.
86. Freeman-Ladd M., Cohen J.B., Carver J.D., et al. The hemodynamic effects of neonatal patent ductus arteriosus shunting on superior mesenteric artery blood flow. J Perinatol 2005, 25:459-462.
87. Sehgal A., McNamara P.J. Does point-of-care functional echocardiography enhance cardiovascular care in the NICU?. J Perinatol 2008, 28:729-735.
88. Baschat A.A., Cosmi E., Bilardo C.M., et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007, 109:253-260.